Sex differences in the effects of Δ9-tetrahydrocannabinol on spatial learning in adolescent and adult rats

Behavioural Pharmacology

Volumn 18, Issue 5-6, 2007, Pages 563-569

  Cha, Young May ^a,b   Jones, Katherine H ^b   Kuhn, Cynthia M ^a   Wilson, Wilkie A ^a,b   Swartzwelder, Harry Scott ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cannabinoids; Development; Female; Memory; Rat; Tetrahydrocannabinol; Water maze

Indexed keywords

DRONABINOL;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG ABUSE; FEMALE; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MORRIS WATER MAZE; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; RAT; SEX DIFFERENCE; TASK PERFORMANCE;

AGE FACTORS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MEMORY; PSYCHOTROPIC DRUGS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SPATIAL BEHAVIOR; TETRAHYDROCANNABINOL;

EID: 34548440801     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282ee7b7e     Document Type: Article

References (51)

1. Belue RC, Howlett AC, Westlake TM, Hutchings DE (1995). The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol 17:25-30.
2. Bernard C, Milh M, Morozov YM, Ben-Ari Y, Freund TF, Gozlan H (2005). Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci 102:9388-9393.
3. Biscaia M, Marin S, Fernandez B, Marco EM, Rubio M, Guaza C, et al. (2003). Chronic treatment with CP 55950 during the peri-adolecent period differentially affects the behavioral responses of male and female rats in adulthood. Psychopharmacology (Berl) 170:301-308.
4. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP (2004). Sex and estrogen influence drug abuse. Trends Pharmacol Sci 25: 273-279.
5. Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS (2006). Differential effects of delta9-THC on spatial learning in adolescent and adult rats. Pharmacol Biochem Behav 83:448-455.
6. Chevaleyre V, Castillo PE (2003). Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-472.
7. Cortright RN, Chandler MP, Lemon PW, DiCarlo SE (1997). Daily exercise reduces fat, protein and body mass in male but not female rats. Physiol Behav 62:105-111.
8. Craft RM (2003). Sex differences in opioid analgesia: 'from mouse to man.' Clin J Pain 19:175-186.
9. Craft RM (2005). Sex differences in behavioral effects of cannabinoids. Life Sci 75:2471-2478.
10. Da S, Takahashi RN (2002). SR141716A prevents delta9-THC induced spatial learning deficit in a Morris type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 26:321-325.
11. Devaud LL, Alele P, Ritu C (2003). Sex differences in the central nervous system actions of ethanol. Crit Rev Neurobiol 15:41-59.
12. DHHS. Results from the 2001 National Household Survey on Drug Abuse. NHSDA Series H-18. 2002: Department of Health and Human Services Pub. No. (SMA) 02-3759. Rockville, Maryland, USA.
13. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 142:295-301.
14. Fadda P, Robinson L, Fratta W, Pertwee RG, Riedel G (2004). Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. Neuropharmacology 47:1170-1179.
15. Fehr KA, Kalant H, LeBlanc AE (1976). Residual learning deficit after heavy exposure to cannabis or alcohol in rats. Science 192:1249-1251.
16. Fried PA, Watkinson B, Gray R (2005). Neurocognitive consequences of marihuana: a comparison with pre-drug performance. Neurotoxicol Teratol 27:231-239.
17. Good M, Day M, Muir J (1999). Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur J Neurosci 11:4476-4480.
18. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932-1936.
19. Irving AJ, Coutts AA, Harvey J, Rae MG, Mackie K, Bewick GS, Pertwee RG (2000). Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience 98:253-262.
20. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR (2004). Impact of cannabis use on brain function in adolescents. Ann NY Acad Sci 1021:384-390.
21. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558.
22. 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture. Neuropharmacology 46:709-715.
23. McEwen BS (1998). Multiple ovarian hormone effects on brain structure and function. J Gender-Specific Med 1:33-41.
24. McEwen BS, Alves SE, Bulloch K, Weiland NG (1997). Ovarian steroids and the brain: implications for cognition and aging. Neurology 48(5 Suppl 7): S8-S15.
25. McLaughlin CR, Martin BR, Compton DR, Abood ME (1994). Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend 36:27-31.
26. Messinis L, Kyprianidou A, Malefaki S, Papathanasopoulos P (2006). Neuropsychological deficits in long-term frequent cannabis users. Neurology 66: 737-739.
27. Mize AL, Alper RH (2000). Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res 859:326-333.
28. Moreno M, Escuredo L, Munoz R, Rodriguez de Fonseca F, Navarro M (2005). Long-term behavioral and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors. Behav Pharmacol 16:423-430.
29. Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM (2005). Randomized double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of delta9- tetrahydrocannabinol (THC) after oral application of THC versus standardized cannabis extract. Ther Drug Monit 27:799-810.
30. Nahas G, Leger C, Tocque B, Hoellinger H (1981). The kinetics of cannabinoid distribution and storage with special reference to the brain and testis. J Clin Pharmacol 21 (8-9 Suppl):208S-214S.
31. Nakamura EM, da Silva EA, Concilio GV, Wilkinson DA, Masur J (1991). Reversible effects of acute and long-term administration of delta-9- tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend 28:167-175.
32. 9-tetrahdrocannabinol in the rat. Biochem Pharmacol 41:1187-1194.
33. O'Shea M, Singh ME, McGregor IS, Mallet PE (2004). Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol 18:502-508.
34. Pope HG, Jacobs A, Mialet J-P, Yurgelun-Todd D, Gruber S (1997). Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 66:179-184.
35. Pope H, Gruber A, Hudson J, Huestis M, Yurgelun-Todd D (2001). Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58:909-915.
36. Rodriguez de Fonseca F, Ramos JA, Bonnin A, Fernandez-Ruiz JJ (1993). Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport 4:135-138.
37. Romero EM, Fernandez B, Sagredo O, Gomez N, Uriguen L, Guaza C, et al. (2002). Antinoceptive, behavioural and neuroendocrine effects of CPP 55,940 in young rats. Brain Res Dev Brain Res 136:85-92.
38. Scharfman H, Mercurio T, Goodman J, Wilson M, MacLusky N (2003). Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor. J Neruosci 23:11641-11652.
39. Seeman P (1999). Images in neuroscience. Brain development, X: pruning during development. Am J Psychiatry 156:168.
40. Shen M, Piser TM, Seybold VS, Thayer SA (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
41. Schneider M, Koch M (2003). Chronic pubertal but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760-1769.
42. Shors TJ, Chua C, Falduto J (2001). Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J Neurosci 21:6292-6297.
43. Stiglick A, Kalant H (1983). Behavioral effects of prolonged administration of delta 9-tetrahydrocannabinol in the rat. Psychopharmacology 80:325-330.
44. Stiglick A, Kalant H (1985). Residual effects of chronic cannabis treatment on behavior in mature rats. Psychopharmacology 85:436-439.
45. Sullivan JM (2000). Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7:132-139.
46. 9-tetrahydrocannabinol-induced behavioral effects in rats. Behav Brain Res 154:77-83.
47. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
48. Varvel SA, Hamm RJ, Martin BR, Lichtman AH (2001). Differential effects of Delta 9-THC on spatial reference and working memory in mice. Psychopharmacology 157:142-150.
49. Wetherington C, Roman A. Editors. Drug Addiction Research and the Health of Women. National Institute on Drug Abuse. 2004: US DHHS.
50. Wilson MA (1996). GABA physiology: modulation by benzodiazepines and hormones. Crit Rev Neurobiol 10:1-37.
51. Woolley CS, Gould E, Frankfurt M, McEwen BS (1990). Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10:4035-4039.